BBIO
Bridgebio Pharma Inc Earnings
$36.85
Earnings Summary
Revenue | $2.73Mn |
Net Profits | $-162.04Mn |
Net Profit Margins | -5931.19% |
Bridgebio Pharma Inc’s revenue fell -33.22% since last year same period to $2.73Mn in the Q3 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated 26.01% jump in its revenue since last 3-months.
Bridgebio Pharma Inc’s net profit jumped 8.45% since last year same period to $-162.04Mn in the Q3 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -120.59% fall in its net profits since last 3-months.
Bridgebio Pharma Inc’s net profit margin fell -37.09% since last year same period to -5931.19% in the Q3 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated -75.05% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.89 |
EPS Estimate Current Year | -0.89 |
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.89 - a 18.35% jump from last quarter’s estimates.
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.89.
Key Ratios
Earning Per Share (EPS) | -1.37 |
Bridgebio Pharma Inc’s earning per share (EPS) fell -43.17% since last year same period to -1.37 in the Q4 2024. This indicates that the Bridgebio Pharma Inc has generated -43.17% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-02-20 | -1.09 | -1.37 | -26.09% |
2024-08-01 | -1.06 | -0.39 | 63.21% |
2024-05-02 | -0.71 | -0.2 | 71.83% |
2024-09-30 | -0.98 | -0.86 | 12.29% |
